Compare TCGL & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCGL | PRE |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | Singapore | Hong Kong |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.5M | 131.3M |
| IPO Year | 2025 | N/A |
| Metric | TCGL | PRE |
|---|---|---|
| Price | $5.22 | $18.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | ★ 917.5K | 144.7K |
| Earning Date | 01-02-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,274,647.00 | ★ $77,079,000.00 |
| Revenue This Year | N/A | $219.28 |
| Revenue Next Year | N/A | $124.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.80 | ★ 201.54 |
| 52 Week Low | $3.95 | $3.10 |
| 52 Week High | $5.91 | $17.99 |
| Indicator | TCGL | PRE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 69.18 |
| Support Level | N/A | $14.02 |
| Resistance Level | N/A | $17.00 |
| Average True Range (ATR) | 0.00 | 1.21 |
| MACD | 0.00 | 0.36 |
| Stochastic Oscillator | 0.00 | 98.20 |
TechCreate Group Ltd is a technology consultancy and advanced software solution provider offering a comprehensive range of payment, cybersecurity, and digital services and solutions. It serves large institutions, financial institutions and telecommunication companies, by providing them with payment, cybersecurity, and digital solutions such as, the development of RTE, RTP, API management and other services, such as cybersecurity defense, IT infrastructure, and cloud services. Its core business areas comprise: (1) the provision of professional services, (2) the sale of software licenses and maintenance licenses, and (3) the sale of hardware solutions.
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.